One Day Advisor

Home  ›  AI  ›  Top Fast-Growing AI Digital Health Companies (2026 Update) Originally published February 9, 2025  |  Updated September 13, 2026 by the Editorial Team Quick Answer The digital health landscape has split in two since our original 2025 list. On the public markets, Hinge Health (HNGE) , Tempus AI (TEM) , and Hims & Hers Health (HIMS) delivered the fastest 2026 revenue growth, while Doximity (DOCS) and Teladoc Health (TDOC) show how differently two "AI turnaround" stories can play out. Privately, OpenEvidence (~$12 billion valuation, reportedly in talks for up to $20 billion) and Abridge ($5.3 billion) have become the two biggest capital magnets in all of digital health by building AI tools physicians actually use daily. Of the five companies on our original 2025 list, two (Doximity, Teladoc) are still public and volatile, one (Sword Health) expanded into mental health at a steady $4 billion valuat...

Updated October 16, 2026 · Originally published 2026 · Written by the One Day Advisor Editorial Team · Reviewed by Frank Yap, MBA. Market figures are as of the dates shown beside each number. Quick Answer Real-world asset (RWA) tokenization puts ownership of assets such as Treasuries, funds, stocks and property on a blockchain. As of October 16, 2026, RWA.xyz counted about $39.2 billion of distributed tokenized assets (excluding stablecoins), roughly 81% above the start of 2026. Tokenized U.S. Treasuries, at about $14.9 billion, are the only mature segment. Forecasts of "$30 trillion" are long-range outliers, not the base case. Disclosure: This article is educational and is not financial, investment, tax or legal advice. It contains no affiliate or sponsored links. Tokenized assets can lose value, and some are restricted to qualified or whitelisted investors. Check eligibility and local rules before buying anything. Contents What is RWA tokenization? How big ...

Last updated: October 16, 2026 ChatGPT can explain a company's competitive advantage. Claude can organize financial research. Gemini can analyze business information and compare investment alternatives. But can any of these AI assistants consistently select stocks that outperform the market after accounting for risk, fees and taxes? That is a much harder question than asking an AI chatbot to list 10 stocks it likes. A convincing answer requires more than persuasive explanations, confident price targets or an impressive backtest. It requires a portfolio with a documented starting date, independently verifiable holdings, a fair benchmark and performance measured over the same period. Research transparency: This article audits published research and establishes a reproducible framework for comparing ChatGPT, Claude and Gemini. It does not claim that we have completed a controlled, forward-looking trial of the three current commercial services. No fabricated portfolio r...